Novoflon (Fluconazole)

Fluconazole, the active ingredient in Novoflon, is an azole antifungal presented as an oral tablet for systemic use. It treats a range of fungal infections, including candidiasis and cryptococcal meningitis, in adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Novoflon as a licensed, GDP‑compliant international pharmaceutical supplier, sourcing the product from EU manufacturers and serving hospitals, pharmacies and clinics worldwide with consistent quality and regulatory compliance. The company ensures timely delivery and supports import documentation for global partners.

Fluconazole is used to treat fungal infections by targeting yeasts and molds in several clinical contexts: - Candidiasis (oropharyngeal, esophageal, vaginal, systemic): eradicates Candida species and relieves infection symptoms. - Cryptococcal meningitis (maintenance therapy): prevents recurrence of infection in the central nervous system. - Dermatophytosis (tinea infections): clears skin infections caused by susceptible dermatophytes. - Systemic candidiasis (bloodstream infection): eliminates invasive Candida species in immunocompromised patients.

Fluconazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: cramp-like discomfort in the abdomen. - Diarrhea: loose stools occurring during therapy. - Rash: mild skin erythema or itching. - Altered taste: temporary metallic or bitter sensation.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - QT prolongation: potential cardiac rhythm disturbances. - Anaphylaxis: rare severe allergic response. - Severe liver failure: rare but life‑threatening hepatic impairment.

Before initiating fluconazole therapy, consider the following safety measures: - Assess liver function: obtain baseline hepatic enzymes and monitor periodically. - Evaluate renal function: adjust dosing in severe renal impairment. - Check for hypersensitivity: avoid use in patients with known azole allergy. - Pregnancy risk: weigh benefits against potential fetal risk; use only if clearly needed. - Review concomitant medications: identify drugs that may interact with fluconazole. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Fluconazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Rifampin: markedly reduces fluconazole exposure, compromising efficacy. - Phenytoin: induces metabolism, lowering fluconazole levels. - Terbinafine: combined use increases risk of hepatic toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: fluconazole may increase INR, requiring closer anticoagulation monitoring. - Cyclosporine: may raise cyclosporine concentrations, necessitating dose adjustment. - Oral hypoglycemics (e.g., sulfonylureas): can enhance hypoglycemic effect, monitor blood glucose.